Get started
BIOGAIA AB SER. BBIOGAIA AB SER. BBIOGAIA AB SER. B

BIOGAIA AB SER. B

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

BIOG_B chart


Full chart

BIOG_B upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪11.15 B‬ SEK
Dividend yield (indicated)
6.26%
Price to earnings Ratio (TTM)
32.8
Basic EPS (TTM)
3.3 SEK
Net income (FY)
‪365.35 M‬ SEK
Revenue (FY)
‪1.30 B‬ SEK
Shares float
‪87.22 M‬
Beta (1Y)
0.26

Employees


Employees (FY)
210
Change (1Y)
−2 −0.94%
Revenue / Employee (1Y)
‪6.17 M‬ SEK
Net income / Employee (1Y)
‪1.74 M‬ SEK

About BIOGAIA AB SER. B


Sector
Health Technology
CEO
Theresa Agnew
Headquarters
Stockholm
Website
biogaia.com
Founded
1990
ISIN
SE0017769995
FIGI
BBG000BGX3S8
BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Pediatrics, Adult Health, and Other. The Pediatrics segment sells drops, oral rehydration solutions, digestive health tablets, and also royalties pertaining to pediatric products. The Adult Health segment include gut health tablets, oral health products, and offers cultures as an ingredient in a licensee's dairy product. The Other segment consists royalties from the development projects, and revenue from packaging solutions. The company was founded by Jan Annwall and Peter Michael Rothschild in 1990 and is headquartered in Stockholm, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BIOG_B news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BIOG_B is 110.2 SEK — it has increased by 0.64% in the past 24 hours. Watch BIOGAIA AB SER. B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange BIOGAIA AB SER. B stocks are traded under the ticker BIOG_B.
BIOG_B stock has risen by 0.82% compared to the previous week, the month change is a 4.95% rise, over the last year BIOGAIA AB SER. B has showed a 13.61% increase.
We've gathered analysts' opinions on BIOGAIA AB SER. B future price: according to them, BIOG_B price has a max estimate of 150.00 SEK and a min estimate of 110.00 SEK. Watch BIOG_B chart and read a more detailed BIOGAIA AB SER. B stock forecast: see what analysts think of BIOGAIA AB SER. B and suggest that you do with its stocks.
BIOG_B reached its all-time high on May 21, 2024 with the price of 136.6 SEK, and its all-time low was 0.8 SEK and was reached on Oct 10, 2002. View more price dynamics on BIOG_B chart.
See other stocks reaching their highest and lowest prices.
BIOG_B stock is 2.30% volatile and has beta coefficient of 0.26. Track BIOGAIA AB SER. B stock price on the chart and check out the list of the most volatile stocks — is BIOGAIA AB SER. B there?
Today BIOGAIA AB SER. B has the market capitalization of ‪11.15 B‬, it has increased by 0.18% over the last week.
Yes, you can track BIOGAIA AB SER. B financials in yearly and quarterly reports right on TradingView.
BIOGAIA AB SER. B is going to release the next earnings report on Feb 12, 2025. Keep track of upcoming events with our Earnings Calendar.
BIOG_B earnings for the last quarter are 0.58 SEK per share, whereas the estimation was 0.64 SEK resulting in a −8.66% surprise. The estimated earnings for the next quarter are 0.57 SEK per share. See more details about BIOGAIA AB SER. B earnings.
BIOGAIA AB SER. B revenue for the last quarter amounts to ‪304.00 M‬ SEK, despite the estimated figure of ‪324.90 M‬ SEK. In the next quarter, revenue is expected to reach ‪333.40 M‬ SEK.
BIOG_B net income for the last quarter is ‪36.60 M‬ SEK, while the quarter before that showed ‪111.01 M‬ SEK of net income which accounts for −67.03% change. Track more BIOGAIA AB SER. B financial stats to get the full picture.
BIOGAIA AB SER. B dividend yield was 1.88% in 2023, and payout ratio reached 52.52%. The year before the numbers were 1.74% and 39.17% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 26, 2024, the company has 210.00 employees. See our rating of the largest employees — is BIOGAIA AB SER. B on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOGAIA AB SER. B EBITDA is ‪483.84 M‬ SEK, and current EBITDA margin is 35.76%. See more stats in BIOGAIA AB SER. B financial statements.
Like other stocks, BIOG_B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOGAIA AB SER. B stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOGAIA AB SER. B technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOGAIA AB SER. B stock shows the neutral signal. See more of BIOGAIA AB SER. B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.